Seeing Is Believing

Currently out of the existing stock ratings of Louise Chen, 631 are a BUY (93.34%), 44 are a HOLD (6.51%), 1 are a SELL (0.15%).
Analyst Louise Chen, currently employed at SCOTIABANK, carries an average stock price target met ratio of 39.43% that have a potential upside of 35.07% achieved within 258 days. Previously, Louise Chen worked at CANTOR FITZGERALD.
Louise Chen’s has documented 1,274 price targets and ratings displayed on 89 stocks. The coverage is on Healthcare, Industrials, Energy, Utilities sectors.
Most recent stock forecast was given on ABBV, AbbVie at 05-Oct-2026.
Analyst best performing recommendations are on NBRV (NABRIVA THERAPEUTICS AG).
The best stock recommendation documented was for HZNP (HORIZON PHARMA PLC) at 2/27/2019. The price target of $26 was fulfilled within 1 day with a profit of $4.15 (18.99%) receiving and performance score of 189.93.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 06-Nov-2024
$4
$0.17 (4.44%)
$3
5 months 5 days ago
(08-May-2026)
4/5 (80%)
$-0.93 (-18.86%)
50
Buy Since 05-May-2026
$11
$7.17 (187.21%)
$6
5 months 8 days ago
(05-May-2026)
1/2 (50%)
$6.25 (131.58%)
391
Buy Since 29-Nov-2016
$12
$8.17 (213.32%)
5 months 8 days ago
(05-May-2026)
0/2 (0%)
$7.25 (152.63%)
Buy Since 28-May-2025
$10
$6.17 (161.10%)
$8
5 months 14 days ago
(29-Apr-2026)
0/3 (0%)
$5.53 (123.71%)
Buy Since 14-May-2025
$16
$12.17 (317.75%)
$16
5 months 28 days ago
(15-Apr-2026)
0/10 (0%)
$12.07 (307.12%)
Which stock is Louise Chen most bullish on?
Which stock is Louise Chen most reserved on?
What Year was the first public recommendation made by Louise Chen?